Publication policy



The ANZMUSC Publication Policy has been adapted from other established network groups. This policy has been developed in alignment with the endorsement principles of ANZMUSC. The purpose of endorsement by ANZMUSC is to indicate that the research question is important, the study design and methodology is of the highest scientific quality, and the results are likely to make a significant impact on practice and/or policy. Endorsement from ANZMUSC therefore comes with a set of requirements to protect the ANZMUSC brand.



  • Manuscripts or theses reporting results obtained from ANZMUSC endorsed studies (including ANZMUSC endorsed sub-studies) or from post-hoc analyses of an ANZMUSC endorsed study, require review and endorsement by the ANZMUSC Executive prior to submission for publication or examination. Manuscripts should comply with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals published by the International Committee of Medical Journal Editors and with guidelines for reporting of specific study types such as CONSORT and STROBE.
  • All manuscripts that describe aspects of the conduct (e.g. protocols or statistical analysis plans) or secondary discussion papers of an ANZMUSC endorsed study must be submitted for review and endorsed by the ANZMUSC Executive prior to submission to a journal for publication. This review may be undertaken by the Chair or Chair-delegate who will determine whether external review is required or whether the Chair or Chair-delegate should recommend endorsement to the Executive without external review.
  • All other manuscripts that are proposed to be published in the name of the group study investigators or the management committee of an ANZMUSC endorsed study (e.g. editorials or review articles) must be submitted for review and endorsed by the ANZMUSC Executive prior to submission to a journal for publication. Such manuscripts proposed to be published in individual name(s) that do not include study data do not require ANZMUSC endorsement.
  • All manuscripts must acknowledge endorsement by the ANZMUSC CTN by including wording along the lines of: The trial has also been endorsed by the ANZMUSC Clinical Trial Network indicating its high priority and quality, importance to consumers/patients, clinicians and policy makers, and its potential to improve patient outcomes.
  • For protocols, the manuscript should include the above as well as the following: Report of the trial will adhere to the ANZMUSC governance and publication policies.
  • Notify ANZMUSC when the study has been accepted for publication, or if the manuscript is not to be published. A copy of all ANZMUSC endorsed manuscripts that are published must be sent to the ANZMUSC Executive Office.
  • The ANZMUSC Executive reserves the right to withdraw endorsement for publication at any stage of the submission for publication process should the scientific quality of a manuscript be deemed substandard or if conflicts cannot be resolved.



The document is adapted with permission from the ANZICS CTN



ANZMUSC Publication Policy

Version 2: February 2020

Approved: 05/02/2020